Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate

OBJECTIVES: At the end of November 2019, a novel coronavirus responsible for respiratory tract infections (COVID-19) emerged in China. Despite drastic containment measures, this virus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread in Asia and Europe. The pandemic is o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Infect Dis
Autors principals: Gendrot, Mathieu, Duflot, Isabelle, Boxberger, Manon, Delandre, Océane, Jardot, Priscilla, Le Bideau, Marion, Andreani, Julien, Fonta, Isabelle, Mosnier, Joel, Rolland, Clara, Hutter, Sébastien, La Scola, Bernard, Pradines, Bruno
Format: Artigo
Idioma:Inglês
Publicat: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7426697/
https://ncbi.nlm.nih.gov/pubmed/32805422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2020.08.032
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars